Introduction: The Convergence of AI and Life SciencesTraditionally, drug discovery is a time-consuming and costly process, ...

DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to ...

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Google DeepMind CEO Demis Hassabis, one of the only people in the world with a Nobel Prize for work on artificial ...

The company’s product is intended to aid the discovery of molecules that can help tackle some of humankind's greatest ...

The human touch matters when developing treatments. The Fast Company Impact Council is an invitation-only membership ...

The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new ...

Google DeepMind CEO, Demis Hassabis, a Nobel laureate, envisions AI revolutionizing healthcare, potentially curing all ...

Clinical trials are vital to drug development but often face challenges such as slow patient recruitment, high costs, and suboptimal trial designs. Today, artificial intelligence (AI) and real ...